Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Chinese study shows some Omicron sub-variants escaping antibodies from Sinopharm COVID vaccine

Ruchika Sharma21 Jun 2022 12:30 PM IST

Neutralising activity against those sub-variants was observed in just 24-48% of subjects who received a BBIBP-CorV booster shot after the two-dose...

Joint Drugs Controller under CBI net for allegedly taking bribe to waive off clinical trial of Biocon's Insulin Aspart injection

Ruchika Sharma21 Jun 2022 11:49 AM IST

Denying allegations, a Biocon Biologics spokesperson said, "All our product approvals are legitimate and backed by science and clinical data. Our...

CBI apprehends persons over bribery case at DCGI office, role of Joint Drugs Controller under scanner

Ruchika Sharma20 Jun 2022 5:40 PM IST

The searches were conducted as part of this operation, officials said.

Aurobindo Pharma buys 51 percent stake in GLS Pharma

Ruchika Sharma20 Jun 2022 4:55 PM IST

Hyderabad: Aurobindo Pharma has recently announced that the Board of Directors of the Company has approved the acquisition of 51% equity shares in...

Alkem Gets CDSCO Panel Nod to Market Synthetic Semaglutide Injection in Multiple Strengths for Type 2 Diabetes

Alkem Labs gets 3 USFDA observations for St Louis facility

Ruchika Sharma20 Jun 2022 3:00 PM IST

Mumbai: Alkems Laboratories has recently announced that the US Food and Drug Administration (USFDA) has issued Form 483 with 3 observations after an...

Lupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine

Lupin, Accenture collaborate to accelerate business efficacy with data driven competencies

Ruchika Sharma20 Jun 2022 1:30 PM IST

"SAP Fiori apps have helped enhance the user experience for Lupin employees with simple and easy-to access data models and analytical reports," the...

Bharat Biotech to submit Covid nasal vaccine trial data to DCGI next month

Ruchika Sharma20 Jun 2022 12:00 PM IST

India's drug controller had in January this year given permission to Bharat Biotech to conduct standalone phase III trials on its Covid-19 nasal...

Pfizer to acquire 8.1 percent stake in Valneva

Ruchika Sharma20 Jun 2022 10:30 AM IST

Valneva is planning to use the proceeds from Pfizer's equity investment to support its Phase 3 development contribution to the Lyme disease program.

Bayer begins Phase I study with GIRK4 inhibitor for atrial fibrillation

Bayer wins fourth Roundup weedkiller case in US

Ruchika Sharma19 Jun 2022 4:00 PM IST

Frankfurt: A U.S. jury found Bayer's Roundup weedkiller did not cause an Oregon man's cancer, the German agriculture and pharmaceuticals company said...

Strides, Incepta partner to expand women health access with WHO prequalified contraceptive

Boehringer Ingelheim, CarthroniX ink pact to pursue small molecule therapeutics in canine oncology

Ruchika Sharma19 Jun 2022 2:30 PM IST

Under the agreement, Boehringer Ingelheim will test a select group of small molecules provided by CarthroniX with the goal of determining their impact...

Bausch Health suspends IPO plan for Solta Medical over challenging market conditions

Ruchika Sharma19 Jun 2022 1:00 PM IST

Bausch, previously known as Valeant Pharmaceuticals, said it would revisit alternative paths for medical aesthetics company Solta in future.

Novartis division Sandoz application for proposed biosimilar Hyrimoz's high concentration formulation accepted by EMA

Ruchika Sharma19 Jun 2022 11:30 AM IST

Upon approval, the Hyrimoz (100 mg/mL) citrate-free HCF would offer reduced injection volume and potentially decrease the number of injections...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok